Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2024
3 years of board service in total across 1 board, counting each seat separately. Longest: CG Oncology Inc., 2 years.
CG Oncology Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 10, 2026 | CG Oncology Inc. | Option exercise | +24,165 | $26.63 | $643,514 |
| Jul 10, 2026 | CG Oncology Inc. | Open-market sale | −24,165 | $75.16 | $1,816,241 |
| Jun 15, 2026 | CG Oncology Inc. | Option exercise | +654 | $3.72 | $2,433 |
| Jun 15, 2026 | CG Oncology Inc. | Open-market sale | −654 | $60.12 | $39,318 |
| Jun 15, 2026 | CG Oncology Inc. | Option exercise | +1,310 | $12.59 | $16,493 |
| Jun 15, 2026 | CG Oncology Inc. | Open-market sale | −1,310 | $60.12 | $78,757 |
| Apr 17, 2026 | CG Oncology Inc. | Option exercise | +15,600 | $36.63 | $571,428 |
| Apr 17, 2026 | CG Oncology Inc. | Open-market sale | −15,600 | $73.01 | $1,138,956 |
| Mar 16, 2026 | CG Oncology Inc. | Option exercise | +654 | $3.72 | $2,433 |
| Mar 16, 2026 | CG Oncology Inc. | Open-market sale | −654 | $63.50 | $41,529 |
| Mar 16, 2026 | CG Oncology Inc. | Option exercise | +1,310 | $12.59 | $16,493 |
| Mar 16, 2026 | CG Oncology Inc. | Open-market sale | −1,310 | $63.50 | $83,185 |
| Jan 9, 2026 | CG Oncology Inc. | Option exercise | +654 | $3.72 | $2,433 |
| Jan 9, 2026 | CG Oncology Inc. | Open-market sale | −654 | $44.16 | $28,881 |
| Jan 9, 2026 | CG Oncology Inc. | Option exercise | +10,491 | $12.59 | $132,082 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.